Todd Bowser

Todd Bowser is an accomplished professional in the biopharmaceutical industry, currently serving as Vice President of Program Management and R&D Strategic Operations at Nimbus Therapeutics since October 2024. With a strong focus on biologic and vaccine development for global health during tenure at the Bill & Melinda Gates Medical Research Institute from August 2022 to October 2024, Todd has also led nursing efforts in novel ADC therapeutic development at Mersana Therapeutics and tuberculosis drug development at the Gates Institute. Prior roles include leadership in oncology R&D at H3 Biomedicine and project and business alliance management at Paratek Pharmaceuticals. Todd's academic background includes a Ph.D. in Mechanistic Enzymology from Baylor University and a BA in Biology from Franklin & Marshall College.